SNY

Sanofi FR
NASDAQ

Real-time Quotes | Nasdaq Last Sale

52.44
+0.37
+0.71%
After Hours: 52.80 +0.36 +0.69% 18:17 09/18 EDT
OPEN
52.59
PREV CLOSE
52.07
HIGH
52.65
LOW
52.13
VOLUME
680.35K
TURNOVER
--
52 WEEK HIGH
55.00
52 WEEK LOW
37.62
MARKET CAP
131.48B
P/E (TTM)
10.53
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average SNY stock price target is 61.38 with a high estimate of 69.00 and a low estimate of 53.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SNY
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Sanofi SA (ADR) stock information, including NASDAQ:SNY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNY stock methods without spending real money on the virtual paper trading platform.